Literature DB >> 1328638

Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors.

S Trumpp-Kallmeyer1, J Hoflack, A Bruinvels, M Hibert.   

Abstract

Hydropathicity analysis of 39 G-protein-coupled receptors (GPCR) reveals seven hydrophobic stretches corresponding to membrane spanning alpha-helices. The alignment of the primary sequences shows a high degree of homology in the GPCR transmembrane regions. 3D models of 39 GPCRs were generated using the refined model of bacteriorhodopsin as a template. Five cationic neurotransmitter receptors (serotonergic 5-HT2, dopaminergic D2, muscarinic m2, adrenergic alpha 2 and beta 2 receptors) were taken as prototypes and studied in detail. The 3D models of the cationic neurotransmitter receptors, together with their primary structure comparison, indicate that the agonist binding site is located near the extracellular face of the receptor and involves residues of the membrane-spanning helices 3, 4, 5, 6, and 7. The binding site consists of a negatively-charged Asp located at the middle of transmembrane helix 3 and a hydrophobic pocket containing conserved aromatic residues on helices 4, 5, 6, and 7. To define the precise receptor-ligand interactions, the natural neurotransmitters were docked into the binding sites. Residues responsible for the affinity, selectivity, and eventually stereospecificity of dopamine, adrenaline, noradrenaline, serotonin, and acetylcholine for their receptors were identified. The ligands are involved in electrostatic interactions as well as hydrogen bonds and specific hydrophobic aromatic interactions. All the GPCRs possess invariant hinge residues, which might be responsible for a conformational change during agonist binding and therefore influence dissociation and association of G-proteins to the receptors. The role of hydrophobic interactions and hydrogen bonds in the conformational change of the receptors, modulating the coupling to the G-protein, is discussed with regard to these residues. The models are in agreement with published data obtained from mutagenesis and labeling studies and represent important working hypotheses to direct future mutagenesis studies. They also enable structure-activity relationship studies and more rational drug design. The 3D models of other G-protein-coupled receptors have been generated in a similar way.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328638     DOI: 10.1021/jm00097a002

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  40 in total

1.  Protein-assisted pericyclic reactions: an alternate hypothesis for the action of quantal receptors.

Authors:  W Radding; T Romo; G N Phillips
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Visualisation and integration of G protein-coupled receptor related information help the modelling: description and applications of the Viseur program.

Authors:  F Campagne; R Jestin; J L Reversat; J M Bernassau; B Maigret
Journal:  J Comput Aided Mol Des       Date:  1999-11       Impact factor: 3.686

3.  Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor.

Authors:  P Andrade-Gordon; B E Maryanoff; C K Derian; H C Zhang; M F Addo; A L Darrow; A J Eckardt; W J Hoekstra; D F McComsey; D Oksenberg; E E Reynolds; R J Santulli; R M Scarborough; C E Smith; K B White
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Molecular recognition of organic ammonium ions in solution using synthetic receptors.

Authors:  Andreas Späth; Burkhard König
Journal:  Beilstein J Org Chem       Date:  2010-04-06       Impact factor: 2.883

5.  Multicomponent Synthesis and Biological Evaluation of a Piperazine-Based Dopamine Receptor Ligand Library.

Authors:  Mattia Stucchi; Peter Gmeiner; Harald Huebner; Giulia Rainoldi; Alessandro Sacchetti; Alessandra Silvani; Giordano Lesma
Journal:  ACS Med Chem Lett       Date:  2015-06-23       Impact factor: 4.345

Review 6.  Molecular recognition of opioid receptor ligands.

Authors:  Brian E Kane; Bengt Svensson; David M Ferguson
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

7.  Modeling and active site refinement for G protein-coupled receptors: application to the beta-2 adrenergic receptor.

Authors:  Stanley R Krystek; S Roy Kimura; Andrew J Tebben
Journal:  J Comput Aided Mol Des       Date:  2006-10-13       Impact factor: 3.686

8.  Structure-lipophilicity relationships of peptides and peptidomimetics.

Authors:  N El Tayar; H Karajiannis; H van de Waterbeemd
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

9.  Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.

Authors:  J Mialet; Y Dahmoune; F Lezoualc'h; I Berque-Bestel; P Eftekhari; J Hoebeke; S Sicsic; M Langlois; R Fischmeister
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

10.  Autoradiographic Evaluation of [(18)F]FECUMI-101, a High Affinity 5-HT1AR Ligand in Human Brain.

Authors:  J S Dileep Kumar; Mark D Underwood; Norman R Simpson; Suham A Kassir; Jaya Prabhakaran; Vattoly J Majo; Mihran J Bakalian; Ramin V Parsey; J John Mann; Victoria Arango
Journal:  ACS Med Chem Lett       Date:  2016-03-13       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.